441 related articles for article (PubMed ID: 18819868)
21. Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness.
Emmer PM; van der Vlag J; Adema GJ; Hilbrands LB
Transplantation; 2006 May; 81(10):1451-9. PubMed ID: 16732184
[TBL] [Abstract][Full Text] [Related]
22. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
[TBL] [Abstract][Full Text] [Related]
23. [Experimental study of immunological tolerance induced by cytotoxic T lymphocyte-associated antigen 4 immunoglobulin in fresh bone allografts].
Guo C; Dai K; Tang T
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 May; 19(5):381-5. PubMed ID: 15960444
[TBL] [Abstract][Full Text] [Related]
24. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.
Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M
Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116
[TBL] [Abstract][Full Text] [Related]
25. [The influence of mycophenolate mofetil upon the maturation and allostimulatory activity of cultured dendritic cell progenitors and the effects of tolerance induction in allograft recipients].
Han CH; Li HF; Wang YX; Zhang M; Wang Y; Yin M; Min ZL; Zheng KL
Zhonghua Yi Xue Za Zhi; 2005 May; 85(19):1327-32. PubMed ID: 16029632
[TBL] [Abstract][Full Text] [Related]
26. Administration of dendritic cells modified by RNA interference prolongs cardiac allograft survival.
Xiang J; Gu X; Zhou Y; Gong X; Qian S; Chen Z
Microsurgery; 2007; 27(4):320-3. PubMed ID: 17477425
[TBL] [Abstract][Full Text] [Related]
27. Donor bone marrow cells play a role in the prevention of accelerated graft rejection induced by semi-allogeneic spleen cells in transplantation.
de Moraes LV; Bueno V; Marguti I; Martins GA; Vallochi AL; Yamamoto GL; Panajotopoulos N; Mengel JO; Rizzo LV
Transpl Immunol; 2008 Feb; 18(4):330-7. PubMed ID: 18158119
[TBL] [Abstract][Full Text] [Related]
28. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.
Wang J; Zhang L; Tang J; Jiang S; Wang X
Transplant Proc; 2008 Jun; 40(5):1612-7. PubMed ID: 18589160
[TBL] [Abstract][Full Text] [Related]
29. Absent mRNA accumulation of Th1 or Th2 cytokines in heart allografts with chimerism-based drug-induced tolerance.
Tomita Y; Zhang QW; Matsuzaki G; Shimizu I; Iwai T; Okano S; Nomoto K; Yasui H
Surg Today; 2005; 35(5):364-70. PubMed ID: 15864417
[TBL] [Abstract][Full Text] [Related]
30. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP
Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783
[TBL] [Abstract][Full Text] [Related]
31. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
PĂȘche H; Heslan M; Usal C; Amigorena S; Cuturi MC
Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
[TBL] [Abstract][Full Text] [Related]
32. Human interleukin-10 transduced fetal liver stem cells prolong survival of mouse skin and heart allografts.
Hase T; Chargui J; Inori F; Yoshimura R; Sembeil R; Nakatani T; Touraine JL
Transplant Proc; 2005; 37(1):287-8. PubMed ID: 15808621
[TBL] [Abstract][Full Text] [Related]
33. Allogenic donor splenocytes pretreated with antisense peptide against B7 prolong cardiac allograft survival.
Chen J; He Q; Zhang R; Chu Y; Wang Y; Liu Q; Xiong S
Clin Exp Immunol; 2004 Nov; 138(2):245-50. PubMed ID: 15498033
[TBL] [Abstract][Full Text] [Related]
34. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
[TBL] [Abstract][Full Text] [Related]
35. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734
[TBL] [Abstract][Full Text] [Related]
36. A limited course of soluble CD83 delays acute cellular rejection of MHC-mismatched mouse skin allografts.
Xu JF; Huang BJ; Yin H; Xiong P; Feng W; Xu Y; Fang M; Zheng F; Wang CY; Gong FL
Transpl Int; 2007 Mar; 20(3):266-76. PubMed ID: 17291220
[TBL] [Abstract][Full Text] [Related]
37. The CD28 peptidemimic can induce mixed chimerism and prolong the survival of cardiac allografts.
Chen J; He Q; Xu H; Su L; Zhang J; Xiong S
Transpl Immunol; 2004 Dec; 13(4):283-8. PubMed ID: 15589741
[TBL] [Abstract][Full Text] [Related]
38. Infusion of donor hepatic non-parenchymal cells prolongs survival of skin allografts in mice: role of microchimerism and IL-4.
Ding XM; Xue WJ; Ji ZZ; Tian PX
Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):34-7. PubMed ID: 17287163
[TBL] [Abstract][Full Text] [Related]
39. Pioglitazone prevents acute and chronic cardiac allograft rejection.
Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
[TBL] [Abstract][Full Text] [Related]
40. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]